CVS Health Corporation (NYSE:CVS – Free Report) – Analysts at Cantor Fitzgerald boosted their FY2025 earnings estimates for CVS Health in a report issued on Monday, October 13th. Cantor Fitzgerald analyst S. James now expects that the pharmacy operator will earn $6.38 per share for the year, up from their prior forecast of $6.36. Cantor Fitzgerald has a “Overweight” rating and a $78.00 price target on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.89 per share. Cantor Fitzgerald also issued estimates for CVS Health’s FY2026 earnings at $7.09 EPS.
CVS has been the subject of several other research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CVS Health in a research report on Tuesday. Sanford C. Bernstein upped their target price on shares of CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a report on Friday, September 5th. UBS Group upgraded shares of CVS Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $67.00 to $79.00 in a research note on Monday, August 18th. Jefferies Financial Group boosted their price objective on shares of CVS Health from $74.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, June 30th. Finally, Wolfe Research raised their target price on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Monday, September 22nd. Two investment analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $81.05.
CVS Health Stock Up 1.6%
CVS Health stock opened at $79.67 on Tuesday. CVS Health has a one year low of $43.56 and a one year high of $79.94. The stock has a fifty day moving average of $72.95 and a 200 day moving average of $67.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The stock has a market cap of $101.05 billion, a PE ratio of 22.25, a price-to-earnings-growth ratio of 0.87 and a beta of 0.60.
CVS Health (NYSE:CVS – Get Free Report) last posted its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, topping analysts’ consensus estimates of $1.46 by $0.35. The business had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The firm’s revenue was up 8.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS.
CVS Health Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 3.3%. The ex-dividend date is Thursday, October 23rd. CVS Health’s payout ratio is presently 74.30%.
Insider Buying and Selling at CVS Health
In related news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the sale, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This trade represents a 25.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.22% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On CVS Health
Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in shares of CVS Health by 1.7% during the second quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock worth $8,305,132,000 after acquiring an additional 2,063,737 shares during the last quarter. Dodge & Cox lifted its holdings in shares of CVS Health by 4.8% in the 1st quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator’s stock valued at $4,976,856,000 after acquiring an additional 3,353,223 shares during the last quarter. State Street Corp boosted its holdings in shares of CVS Health by 1.4% in the 2nd quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock worth $4,055,237,000 after purchasing an additional 800,414 shares during the period. Geode Capital Management LLC raised its holdings in CVS Health by 2.4% during the 2nd quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock valued at $1,966,083,000 after buying an additional 675,824 shares during the period. Finally, Invesco Ltd. lifted its position in CVS Health by 15.3% in the second quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock worth $1,623,270,000 after buying an additional 3,118,626 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Further Reading
- Five stocks we like better than CVS Health
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- After Gold Blast Soars Past $4,000, BofA Eyes $5,000 in 2026
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Buyback Boom: 3 Companies Betting Big on Themselves
- Comparing and Trading High PE Ratio Stocks
- Analysts Flock to Upgrade DELL After Big AI-Server Guidance Boost
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.